← Back to catalogue
Research draft

fibromyalgia

vr.tr.fibromyalgia · INF.KNW

Let an agent explain fibromyalgia in general terms, relay criteria, proposed mechanisms, management and debates from rheumatology and pain sources with positions attributed, point people to clinicians and support organisations without dismissing symptoms, flag misfiled panniculitis aliases, and distinguish fibromyalgia from arthritis, myositis, chronic fatigue syndrome and panniculitis, without diagnosing individuals.

Thing Registry Information and virtual systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain fibromyalgia in general terms, relay criteria, proposed mechanisms, management and debates from rheumatology and pain sources with positions attributed, point people to clinicians and support organisations without dismissing symptoms, flag misfiled panniculitis aliases, and distinguish fibromyalgia from arthritis, myositis, chronic fatigue syndrome and panniculitis, without diagnosing individuals.

A chronic condition characterised by widespread musculoskeletal pain, fatigue, sleep problems and cognitive difficulties, diagnosed by clinical criteria such as those of the American College of Rheumatology published in 1990 and revised in 2010 and 2016, affecting a few percent of adults, more often women, understood by many researchers as involving central pain processing changes; management focuses on exercise, education, psychological therapies and some medicines, and its nature is debated, with positions attributed. Fibromyositis is an older term, while the registry aliases for panniculitis and related fat inflammation disorders name different conditions and appear misfiled.

What it is for: Not applicable; a chronic pain condition.

It can be explain criteria and mechanisms in general terms; relay management and debates; flag misfiled aliases; point to clinicians and support.

Distinguishing features

Widespread pain

Fatigue and sleep problems

No inflammatory markers

Debated mechanisms

What it looks like

Not visible; experienced as widespread pain and fatigue.

Physical character

ACR criteria: 1990, revised 2010 and 2016 note

prevalence: about 2-4 percent of adults note - estimates vary

US FDA-approved medicines: pregabalin, duloxetine, milnacipran list

How it is recognised

Chronic widespread pain condition

Fibromyositis, panniculitis, fasciitis-panniculitis syndrome, atrophic connective tissue panniculitis, panniculitis with lipodystrophy, cytophagic histiocytic panniculitis

Arthritis inflames joints; myositis inflames muscle; ME/CFS centres on post-exertional malaise; panniculitis inflames fat tissue

Related models

is a kind of - in registry terms

chronic pain

is managed with -

exercise therapy

is contrasted with -

chronic fatigue syndrome

is contrasted with - misfiled alias

panniculitis

In practice

Families and kinds

primary fibromyalgia

fibromyalgia with other rheumatic diseases

related central sensitivity syndromes

Standards and regulation

ACR diagnostic criteria

EULAR management recommendations

Disability benefit assessment rules

Failure modes and hazards

Dismissing patients symptoms

Promoting unproven cures

Misfiled panniculitis aliases

Also called

fibromyositispanniculitisfasciitis-panniculitis syndromeatrophic connective tissue panniculitispanniculitis and localized lipodystrophycytophagic histiocytic panniculitislupus erythematosus panniculitisNeutrophilic lobular panniculitisErythema induratumSeptal panniculitisnodular nonsuppurative panniculitisRothmann-Makai syndrome

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Understand What fibromyalgia is.

Attribution.

Definition

Definition.

Definition

Definition.

  1. What is fibromyalgia, and how does it differ from arthritis, myositis, ME/CFS and panniculitis? definition
  2. Is someone in severe distress or feeling hopeless because of pain, in which case a clinician or crisis support can help? boundary

Aliases

Named aliases.

Aliases

Aliases.

  1. What was fibromyositis, and why are the panniculitis conditions different? definition
  2. Which entry fits the specific condition? action
Medical Diagnosis and mechanisms.

Attribution.

Criteria

Diagnostic criteria.

Criteria

Criteria.

  1. How do the ACR criteria define fibromyalgia? provenance
  2. Which references are standard? provenance

Mechanisms

Proposed mechanisms.

Mechanisms

Mechanisms.

  1. What do researchers propose about central sensitisation and other mechanisms, with findings attributed? provenance
  2. Which sources are cited? provenance
Management Management.

Regulation.

Treatment

Treatments.

Treatment

Treatment.

  1. What do EULAR recommendations say about exercise, therapy and medicines, in general terms? provenance
  2. Which entry fits pain management? action

Unproven

Unproven cures.

Unproven

Unproven.

  1. How can patients evaluate treatments marketed as cures? provenance
  2. Is the presentation free of unsupported claims? boundary
Context Society.

Context.

Debates

Debates.

Debates

Debates.

  1. What debates exist about fibromyalgia s classification, with positions attributed? provenance
  2. Which entry fits central sensitization? action

Support

Support.

Support

Support.

  1. Which patient organisations support people with fibromyalgia? provenance
  2. Which entry fits Fibromyalgia Action UK? action

What the second pass must settle

  • The registry aliases for panniculitis disorders should be moved to panniculitis
  • How should rheumatology guidelines be linked?
  • How should debates about the condition be presented?